N. Lokugamage

发表

Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain

T. Ikegami, Hoai J. Ly, N. Lokugamage, 2017, PloS one.

Rescue of infectious Arumowot virus from cloned cDNA: Posttranslational degradation of Arumowot virus NSs protein in human cells

T. Ikegami, N. Lokugamage, Hoai J Hallam, 2019, PLoS neglected tropical diseases.

Serological analysis of hemorrhagic fever with renal syndrome (HFRS) patients in Far Eastern Russia and identification of the causative hantavirus genotype

T. Mizutani, K. Lokugamage, B. Cui, 2003, Archives of Virology.

Genetic Characterization of Hantaviruses Transmitted by the Korean Field Mouse (Apodemus peninsulae), Far East Russia

T. Mizutani, K. Maeda, T. Iwasaki, 2002, Emerging infectious diseases.

N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN

Alexander N. Freiberg, Terence E. Hill, M. Huante, 2016, Viruses.

Characterization of Rift Valley Fever Virus MP-12 Strain Encoding NSs of Punta Toro Virus or Sandfly Fever Sicilian Virus

Alexander N. Freiberg, B. Tigabu, B. Gong, 2013, PLoS neglected tropical diseases.

Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR.

T. Ikegami, Birte Kalveram, Sabarish V. Indran, 2013, Virology.

Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.

C. Peters, S. Makino, J. Morrill, 2013, Vaccine.

Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.

C. Peters, S. Makino, J. Morrill, 2013, Vaccine.

Comparison of virulence of various hantaviruses related to hemorrhagic fever with renal syndrome in newborn mouse model.

T. Mizutani, T. Iwasaki, K. Lokugamage, 2004, The Japanese journal of veterinary research.

Development of an efficient method for recovery of Puumala and Puumala-related viruses by inoculation of Mongolian gerbils.

T. Mizutani, K. Lokugamage, K. Yoshimatsu, 2003, The Journal of veterinary medical science.

Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells

T. Ikegami, N. Lokugamage, 2017, npj Vaccines.

The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype

T. Ikegami, N. Lokugamage, Shoko Nishiyama, 2016, Journal of Virology.

Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments

Alexander N. Freiberg, Jennifer K. Smith, Terence E. Hill, 2015, Journal of Virology.

1 1 Rift Valley fever virus MP-12 vaccine is fully attenuated by a combination of 2 partial attenuations in the S-, Mand L-segments 3 4

Alexander N. Freiberg, Jennifer K. Smith, Terence E. Hill, 2015 .

Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR

Alexander N. Freiberg, Jennifer K. Smith, Terence E. Hill, 2016, Virulence.

Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice.

Alexander N. Freiberg, Jennifer K. Smith, B. Tigabu, 2013, The Journal of general virology.

Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.

G. Bettinger, C. Peters, J. Morrill, 2016, Vaccine.

Synthesis of Seoul virus RNA and structural proteins in cultured cells

T. Mizutani, K. Lokugamage, K. Yoshimatsu, 2003, Archives of Virology.

Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression

T. Ikegami, N. Lokugamage, Shoko Nishiyama, 2016, Viruses.

Epizootiological survey of hantavirus among rodent species in Ningxia Hui Autonomous Province, China.

T. Mizutani, K. Lokugamage, K. Yoshimatsu, 2001, The Japanese journal of veterinary research.

Antigen-Based Nano-Immunotherapy Controls Parasite Persistence, Inflammatory and Oxidative Stress, and Cardiac Fibrosis, the Hallmarks of Chronic Chagas Cardiomyopathy, in A Mouse Model of Trypanosoma cruzi Infection

N. Garg, I. Chowdhury, N. Lokugamage, 2020, Vaccines.

TcG2/TcG4 DNA Vaccine Induces Th1 Immunity Against Acute Trypanosoma cruzi Infection: Adjuvant and Antigenic Effects of Heterologous T. rangeli Booster Immunization

J. C. Vazquez-Chagoyán, N. Garg, Shivali Gupta, 2019, Front. Immunol..

A comparative epidemiological study of hantavirus infection in Japan and Far East Russia.

K. Yoshii, T. Iwasaki, K. Lokugamage, 2007, The Japanese journal of veterinary research.

Epizootiological and Epidemiological Study of Hantavirus Infection in Japan

T. Mizutani, Hiroshi Sato, K. Yoshii, 2004, Microbiology and immunology.

Application of Droplet Digital PCR to Validate Rift Valley Fever Vaccines.

T. Ikegami, Hoai J. Ly, N. Lokugamage, 2016, Methods in molecular biology.

Genetic Subpopulations of Rift Valley Fever Virus Strains ZH548 and MP-12 and Recombinant MP-12 Strains

J. Morrill, Alexander N. Freiberg, T. Ikegami, 2012, Journal of Virology.

Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease

U. Marathi, N. Garg, P. Vanderslice, 2021, NPJ vaccines.

Effects of Acute and Chronic Trypanosoma cruzi Infection on Pregnancy Outcomes in Mice: Parasite Transmission, Mortality, Delayed Growth, and Organ Damage in Pups.

N. Garg, N. Lokugamage, Lizette E Rios, 2022, The American journal of pathology.

Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model

J. Richt, J. Morrill, W. Wilson, 2017, PloS one.

Correction: Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA

C. Peters, S. Makino, J. Morrill, 2010, PLoS ONE.

Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA

C. Peters, S. Makino, J. Morrill, 2010, PloS one.

The Dominant-Negative Inhibition of Double-Stranded RNA-Dependent Protein Kinase PKR Increases the Efficacy of Rift Valley Fever Virus MP-12 Vaccine

S. Fukushi, S. Morikawa, C. K. Tseng, 2012, Journal of Virology.

Experimental Nanovaccine Offers Protection Against Repeat Exposures to Trypanosoma cruzi Through Activation of Polyfunctional T Cell Response

N. Garg, I. Chowdhury, N. Lokugamage, 2020, Frontiers in Immunology.

Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.

Alexander N. Freiberg, Jennifer K. Smith, T. Ikegami, 2017, Vaccine.

Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells

T. Ikegami, N. Lokugamage, 2017, npj Vaccines.

Modes of hantavirus transmission in a population of Clethrionomys rufocanus bedfordiae inferred from mitochondrial and microsatellite DNA analyses

T. Mizutani, K. Lokugamage, B. Cui, 2004, Archives of Virology.

Instructions for use Title Comparison of virulence of various hantaviruses related to hemorrhagic fever with renal syndrome in newborn mouse model

T. Mizutani, T. Iwasaki, K. Lokugamage, 2017 .

Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice.

Alexander N. Freiberg, Jennifer K. Smith, B. Tigabu, 2013, The Journal of general virology.

Subunit nanovaccine elicited T cell functional activation controls Trypanosoma cruzi mediated maternal and placental tissue damage and improves pregnancy outcomes in mice

N. Garg, I. Chowdhury, N. Lokugamage, 2023, NPJ Vaccines.